PF4 and neoplasm: Although useful in cancer diagnosis, the exact mechanisms of transition of platelets to the TEP phenotype are unclear but appear to involve the systemic exchange of platelet- and tumor-derived biomolecules [70], possibly implying their involvement with TME-derived PF4.